Indication
Coronary Artery Stenosis
4 clinical trials
7 products
Clinical trial
XIENCE V® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE V® USA DAPT Cohort) (XVU-AV DAPT)Status: Completed, Estimated PCD: 2015-02-01
Product
Placebo + AspirinClinical trial
Impact of a Mobile Technology Enabled Corrie Cardiac Rehabilitation Program on Functional Status and Cardiovascular Outcomes (mTECH-Rehab): A Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Efficacy and Safety of Comprehensive Treatment in Patients With Inflammation-associated Rapidly-progressive Coronary Artery Disease (IR-CAD): a Self-controlled Cohort StudyStatus: Recruiting, Estimated PCD: 2025-09-01
Product
Immunosuppressive therapyProduct
Supportive therapiesClinical trial
Antiplatelet Agents in Patients With Intermediate Coronary Artery Stenosis and Negative Fractional Flow ReserveStatus: Active (not recruiting), Estimated PCD: 2020-12-31
Product
Antiplatelet Agents